Issue 29 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

37

No.

29

July 22, 2011Jul 22, 2011

Free

DOWNLOAD THE PDF

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

Part One Of A Two-Part Interview With NCI Director Harold Varmus

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

Richard Pazdur’s Comments to ODAC

Department of Defense Offering $16 Million in Cancer Research Grants

Recent Issues

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026